Anesthetic Drugs and Cancer Progression
- PMID: 32833387
- PMCID: PMC7494601
- DOI: 10.1097/ALN.0000000000003510
Anesthetic Drugs and Cancer Progression
Conflict of interest statement
Competing Interests: Dr. Sood has the following conflict of interest: Merck (Scientific advisory board), Kiyatec (Consulting), M-Trap (research grant), BioPath (shareholder).
Comment on
-
Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery.Anesthesiology. 2020 Oct 1;133(4):764-773. doi: 10.1097/ALN.0000000000003440. Anesthesiology. 2020. PMID: 32930730
References
-
- Sessler DI, Riedel B: Anesthesia and Cancer Recurrence. Anesthesiology 2019; 130: 3–5 - PubMed
-
- Makito KM K; Fushimi K; Yasunaga H: Volatile versus total intravenous anesthesia for cancer prognosis in patients having digestive cancer surgery: A nationwide retrospective cohort study. Anesthesiology 2020 - PubMed
-
- Matsuda S, Fujimori K, Kuwabara K, Ishikawa KB, Fushimi K: Diagnosis Procedure Combination as an Infrastructure for the Clinical Study. Asian Pacific Journal of Disease Management 2011; 5: 81–87
-
- Wigmore TJ, Mohammed K, Jhanji S: Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology 2016; 124: 69–79 - PubMed
-
- Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, Mayers DB, Meyer-Treschan TA, Grady M, Tan EY, Ayad S, Mascha EJ, Buggy DJ, Tan G, Zhang Z, Keane H, Stokes M, Zotti O, Gnant M, Perez-Protto S, Wu J, Parra-Sanchez I, Yang D, Hassan M, Tey JBL: Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. The Lancet 2019 - PubMed
